Valuation: Dr. Martens plc

Market Cap 607M 806M 727M 671M 1.15B 75.62B 1.18B 8.05B 3.21B 40.5B 3.03B 2.96B 129B P/E 2027 *
12.9x
P/E 2028 * 10.3x
Enterprise Value 805M 1.07B 964M 890M 1.52B 100B 1.56B 10.67B 4.25B 53.7B 4.01B 3.93B 171B EV / Sales 2027 *
1.03x
EV / Sales 2028 * 0.95x
Free-Float
57.55%
Yield 2027 *
3.95%
Yield 2028 * 3.99%
1 day+0.16%
1 week-1.71%
Current month-3.35%
1 month-6.76%
3 months-24.34%
6 months-2.46%
Current year-17.23%
1 week 62.7
Extreme 62.7
67.9
1 month 61.6
Extreme 61.6
72
Current year 59.15
Extreme 59.15
90
1 year 59.15
Extreme 59.15
90.4
3 years 43.02
Extreme 43.02
121.6
5 years 43.02
Extreme 43.02
448.2
10 years 43.02
Extreme 43.02
521.6
Manager TitleAgeSince
Chief Executive Officer 55 06/01/2025
Director of Finance/CFO 53 13/05/2024
Chief Operating Officer - -
Director TitleAgeSince
Director/Board Member 53 01/01/2021
Director/Board Member 55 10/07/2025
Director/Board Member 52 01/01/2021
Date Insider Type Main position Quantity % Market Cap. Importance
5/29/26 A Free

Chief Executive Officer

2,732,653 0.2823%
5/29/26 A Free

Chief Financial Officer

2,100,151 0.2170%
5/13/26 A Buy

Chief Financial Officer

233 0.0000%
Change 5-day change 1-year change 3-year change Capi.($)
-0.63%-1.71%-25.37%-46.63% 814M
-0.91%-5.36%-39.32%-63.22% 57.44B
-0.70%+5.35%+12.30%+3.63% 34.29B
-0.62%+6.71%+37.87%+316.52% 22.18B
+0.03%-10.12%-1.34%+30.69% 11.6B
-1.57%-0.82%+6.86%-15.62% 11.99B
+0.20%+0.09%+113.31%+107.04% 7.3B
-8.39%-9.33%-40.46%-28.51% 6.91B
-1.77%-1.77%-6.82%-8.11% 6.63B
-2.50%+0.91%+63.44%-51.23% 4.46B
Average -1.56%+1.89%+12.05%+24.45% 16B
Weighted average by Cap. -1.12%+2.72%-1.01%+24.13%

Financials

2027 *2028 *
Net sales 778M 1.03B 932M 861M 1.47B 96.98B 1.51B 10.32B 4.11B 51.94B 3.88B 3.8B 165B 816M 1.08B 977M 903M 1.54B 102B 1.58B 10.82B 4.31B 54.47B 4.07B 3.98B 173B
Net income 48.4M 64.3M 57.95M 53.54M 91.57M 6.03B 93.83M 642M 256M 3.23B 241M 236M 10.28B 59.88M 79.54M 71.69M 66.23M 113M 7.46B 116M 794M 316M 4B 299M 292M 12.71B
Net Debt 198M 263M 237M 219M 374M 24.65B 383M 2.62B 1.05B 13.2B 986M 965M 42.01B 170M 226M 204M 188M 322M 21.18B 330M 2.25B 898M 11.34B 848M 830M 36.1B
Projected Income Statement - Annual - Dr. Martens plc
Logo Dr. Martens plc
Dr. Martens plc is a United Kingdom-based company, which designs, develops, procures, markets, sells and distributes footwear, under the Dr. Martens brand. The Company's segments include Europe, the Middle East and Africa (EMEA); Americas; and Asia-Pacific (APAC). Its product segments include boots, shoes, sandals, and bags & other. Its boots offerings include the 1460 8-eye boot, 2976 Chelsea boot, Jadon, Bex and Sinclair. Its shoes offerings include 1461 3-eye shoe and the Adrian tassel loafer, as well as franchises/families such as Buzz and Lowell. Its sandals range includes Blaire and Gryphon silhouettes and also includes the mules range, led by the Zebzag. Its bag range is focused on key silhouettes of leather bags, such as the Kiev backpack, the heart-shaped bag and its weekender bag. This category also includes socks, laces and shoe care. The Company offers its products through direct-to-consumer channel via its ecommerce platforms and its stores, among others.
Employees
2,377
Date Price Change Volume
11/11/26 GBX 63.40 -0.63% 1,146,227
10/11/26 GBX 63.80 -0.62% 717,251
09/11/26 GBX 64.20 +0.31% 800,842
06/11/26 GBX 64.00 -0.47% 1,648,916
05/11/26 GBX 64.30 -2.72% 1,227,190
Trader
Investor
Global
Quality
ESG MSCI
AAA
MarketScreener Ratings - Dr. Martens plc
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
6
Last Close Price
0.6340GBP
Average target price
0.9517GBP
Spread / Average Target
+50.11%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Dr. Martens plc
  1. Stock Market
  2. Stocks
  3. DOCS Stock